(Q40460706)

20 September 2017

title

Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique. (English)

1 reference

20 September 2017

0 references

0 references

1 reference

10

Dubois MC

1 reference

20 September 2017

11

Heppner DG

1 reference

20 September 2017

Macete E

1

1 reference

20 September 2017

Aponte JJ

2

1 reference

20 September 2017

Guinovart C

3

1 reference

20 September 2017

Sacarlal J

4

1 reference

20 September 2017

Ofori-Anyinam O

5

1 reference

20 September 2017

Mandomando I

6

1 reference

20 September 2017

Espasa M

7

1 reference

20 September 2017

Bevilacqua C

8

1 reference

20 September 2017

Leach A

9

1 reference

20 September 2017

Tello L

12

1 reference

20 September 2017

Milman J

13

1 reference

20 September 2017

Cohen J

14

1 reference

20 September 2017

Dubovsky F

15

1 reference

20 September 2017

Tornieporth N

16

1 reference

20 September 2017

Thompson R

17

1 reference

20 September 2017

Alonso PL

18

1 reference

20 September 2017

publication date

1 January 2007

1 reference

Tropical Medicine and International Health

20 September 2017

published in

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

37-46

1 reference

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

Epidemiology and clinical presentation of respiratory syncytial virus infection in a rural area of southern Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

Malaria in southern Mozambique: incidence of clinical malaria in children living in a rural community in Manhiça district

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2006.01754.X

10.1111/J.1365-3156.2006.01754.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference